Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.

Oncotarget - 22 Sept 2015

Stangeland Biljana, Mughal Awais A, Grieg Zanina, Sandberg Cecilie Jonsgar, Joel Mrinal, Nygård Ståle, Meling Torstein, Murrell Wayne, Vik Mo Einar O, Langmoen Iver A

Abstract excerpt

Glioblastoma (GBM) is both the most common and the most lethal primary brain tumor. It is thought that GBM stem cells (GSCs) are critically important in resistance to therapy. Therefore, there is a strong rationale to target these cells in order to develop new molecular therapies.To identify mole...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Drug Design
Share to Glioblastoma
Share to Heterografts

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Molecular Targeted Therapy

Share to Neoplasm Transplantation

Share to Neoplastic Stem Cells

Share to Neural Stem Cells

Share to Protein Interaction Maps

Source

Open in PubMed Open full text

Identifiers

PMID: 26295306
DOI: 10.18632/oncotarget.4613
PMCID: PMC4694895

Genes

CDC6
CENPA
DEPDC1
HMMR
KIF15
PBK
DLGAP5
GSC
LPAR6
MCC
NOL4
RAPGEF4
RHBDD1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-26295306-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.PMID 26295306Read ↗

Evaluation of Secretome Biomarkers in Glioblastoma Cancer Stem Cells: A Bioinformatics AnalysisSemantic proximity Read ↗

Identification of new targets for glioblastoma therapy based on a DNA expression microarraySemantic proximity Read ↗

Molecular pathology in adult high‐grade gliomas: from molecular diagnostics to target therapiesSemantic proximity Read ↗

Identification of Differentially Expressed Genes in Different Glioblastoma Regions and Their Association with Cancer Stem Cell Development and Temozolomide ResponseSemantic proximity Read ↗

Gene Expression Profiling of Glioblastoma to Recognize Potential Biomarker CandidatesSemantic proximity Read ↗

Comparative proteogenomic characterization of glioblastomaSemantic proximity Read ↗

Integrating Multi-Omics Analysis for Enhanced Diagnosis and Treatment of Glioblastoma: A Comprehensive Data-Driven ApproachSemantic proximity Read ↗

Identification of novel genes associated with diagnosis and prognosis in glioblastomaSemantic proximity Read ↗

Unveiling novel cell clusters and biomarkers in glioblastoma and its peritumoral microenvironment at the single-cell perspectiveSemantic proximity Read ↗

Genomic, epigenomic and transcriptomic landscape of glioblastoma.Semantic proximity Read ↗

The identification of key genes and pathways in glioblastoma by bioinformatics analysisSemantic proximity Read ↗

Identification of Potential Biomarkers in Glioblastoma through Bioinformatic Analysis and Evaluating Their Prognostic ValueSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.